Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Dyclone
2. Dyclonine
3. Dyclonine Hcl
4. Sucrets
5. Tanac
1. 536-43-6
2. Dyclonine Hcl
3. Dyclone
4. Dyclothane
5. Dyclocaine Hydrochloride
6. Tanaclone
7. Dyclonine (hydrochloride)
8. Diclonina
9. 4'-butoxy-3-piperidinopropiophenone Hydrochloride
10. 1-propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)-, Hydrochloride
11. P-267
12. Nsc-23018
13. 1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one;hydrochloride
14. Diclonia
15. Dyclonine Hydrochloride [usp]
16. Mls000069532
17. Zec193879q
18. Dyclocainum
19. Mfcd00035386
20. Smr000038382
21. Dsstox_cid_25323
22. Dsstox_rid_80802
23. Dsstox_gsid_45323
24. Dyclonine Hydrochloride (usp)
25. Wln: T6ntj A2vr Do4 &gh
26. Chebi:4725
27. Dycloninehydrochloride
28. Dyclonine, Hydrochloride
29. Ncgc00016498-01
30. Cas-536-43-6
31. Einecs 208-633-6
32. Nsc 23018
33. 4-n-butoxy-.beta.-(1-piperidyl)propiophenone Hydrochloride
34. Unii-zec193879q
35. Sr-01000000032
36. S 154
37. C 5422
38. Dyclopro (tn)
39. Prestwick_674
40. Dyclone (tn)
41. Piperidine, 1-(2-(4-butoxybenzoyl)ethyl), Hydrochloride
42. Opera_id_1265
43. Mls001077359
44. Mls002222240
45. Schembl317219
46. Spectrum1500268
47. Propiophenone, 4'-butoxy-3-piperidino-, Hydrochloride
48. Chembl1200478
49. Dtxsid6045323
50. Hy-b0364a
51. Hms1568f10
52. Hms1920k06
53. Pharmakon1600-01500268
54. Bcp28402
55. Nsc23018
56. Nsc25588
57. Dyclonine Hydrochloride [mi]
58. Tox21_110459
59. Ccg-40231
60. Nsc-25588
61. Nsc756745
62. S2041
63. Akos015951364
64. Tox21_110459_1
65. Ac-8346
66. Ds-3341
67. Dyclonine Hydrochloride [mart.]
68. Dyclonine Hydrochloride [vandf]
69. Nsc-756745
70. Dyclonine Hydrochloride [usp-rs]
71. Dyclonine Hydrochloride [who-dd]
72. Ncgc00016498-08
73. Ncgc00094662-01
74. Ncgc00094662-02
75. Ncgc00094662-03
76. Ncgc00094662-04
77. Sy066681
78. D4303
79. Dyclonine Hydrochloride [orange Book]
80. Ft-0625635
81. Sw196829-3
82. Dyclonine Hcl;dyclone;dyclocaine Hydrochloride
83. D00735
84. Dyclonine Hydrochloride [usp Monograph]
85. N12006
86. A829700
87. Sr-01000000032-4
88. W-105718
89. Q27106453
90. 4-butoxy-3-piperidinopropiophenone Hydrochloride
91. 4-n-butoxy-.beta.-piperidonopropiophenone Hydrochloride
92. 1-(4-butoxyphenyl)-3-(1-piperidinyl)-1-propanone Hydrochloride
93. 1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one;hydron;chloride
94. 1-propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)hydrochloride
95. Dyclonine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
96. Dyclonine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
| Molecular Weight | 325.9 g/mol |
|---|---|
| Molecular Formula | C18H28ClNO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 8 |
| Exact Mass | 325.1808568 g/mol |
| Monoisotopic Mass | 325.1808568 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 292 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-04-24
Pay. Date : 2015-06-08
DMF Number : 28587
Submission : 2015-02-18
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19497
Submission : 2006-03-31
Status : Active
Type : II

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4032
Submission : 1980-12-23
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 84317-103
Start Marketing Date : 2024-06-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT


NDC Package Code : 62991-1661
Start Marketing Date : 2009-05-12
End Marketing Date : 2027-09-05
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : Complete
Rev. Date : 2017-04-24
Pay. Date : 2015-06-08
DMF Number : 28587
Submission : 2015-02-18
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19497
Submission : 2006-03-31
Status : Active
Type : II

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4032
Submission : 1980-12-23
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 84317-103
Start Marketing Date : 2024-06-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 62991-1661
Start Marketing Date : 2009-05-12
End Marketing Date : 2027-09-05
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Established in 1991, Pharm-Rx is an importer and distributor of active ingredients serving the pharmaceutical, nutritional supplement, and food industries. The company follows a hi...
China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM services and Finished ...
About the Company : Sichuan Taienkang Pharmaceutical Co., Ltd., established in 2020, is a subsidiary of Guangdong Taienkang Pharmaceutical Co., Ltd. The company specializes in the R&D, production, and...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : DYCLONE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 9925
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : DYCLONE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 9925
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : DYCLOPRO
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.5%
Approval Date : 2018-11-20
Application Number : 200480
RX/OTC/DISCN : RX
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : DYCLOPRO
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 1%
Approval Date : 2018-11-20
Application Number : 200480
RX/OTC/DISCN : RX
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Gel
Dosage Strength : 100MG
Packaging : 10mL:100mgx 12vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 10mL:100mgx 12vials
Regulatory Info :
Dosage : Gel
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : China

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Market Place
Reply
03 Feb 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
78
PharmaCompass offers a list of Dyclonine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dyclonine manufacturer or Dyclonine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dyclonine manufacturer or Dyclonine supplier.
A Dyclone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dyclone, including repackagers and relabelers. The FDA regulates Dyclone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dyclone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dyclone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Dyclone supplier is an individual or a company that provides Dyclone active pharmaceutical ingredient (API) or Dyclone finished formulations upon request. The Dyclone suppliers may include Dyclone API manufacturers, exporters, distributors and traders.
click here to find a list of Dyclone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Dyclone DMF (Drug Master File) is a document detailing the whole manufacturing process of Dyclone active pharmaceutical ingredient (API) in detail. Different forms of Dyclone DMFs exist exist since differing nations have different regulations, such as Dyclone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dyclone DMF submitted to regulatory agencies in the US is known as a USDMF. Dyclone USDMF includes data on Dyclone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dyclone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dyclone suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dyclone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dyclone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dyclone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dyclone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dyclone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dyclone suppliers with NDC on PharmaCompass.
Dyclone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dyclone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dyclone GMP manufacturer or Dyclone GMP API supplier for your needs.
A Dyclone CoA (Certificate of Analysis) is a formal document that attests to Dyclone's compliance with Dyclone specifications and serves as a tool for batch-level quality control.
Dyclone CoA mostly includes findings from lab analyses of a specific batch. For each Dyclone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dyclone may be tested according to a variety of international standards, such as European Pharmacopoeia (Dyclone EP), Dyclone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dyclone USP).